» Articles » PMID: 33194037

Long Noncoding RNA MIR4435-2HG Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through the MiR-22-3p/YWHAZ Axis

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2020 Nov 16
PMID 33194037
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) play the critical biological role in many malignant tumours. MIR4435-2HG has been proven to be a novel oncogenic lncRNA. However, the exact role and mechanism of MIR4435-2HG in hepatocellular carcinoma (HCC) remain unclear. Here, we found that MIR4435-2HG is overexpressed in HCC tissue compared to normal controls and that high level of MIR4435-2HG indicates a poorer prognosis in HCC patients. MIR4435-2HG enhances the growth and metastasis ability of HCC cells. MIR4435-2HG promotes the expression of YWHAZ by sponging miR-22-3p to liberate YWHAZ mRNA transcripts. MIR4435-2HG facilitates the proliferation and metastasis of HCC by modulating the miR-22-3p/YWHAZ axis. These results demonstrated the role and mechanism of MIR4435-2HG in malignant progression of HCC. MIR4435-2HG may be used as the prognostic marker and treatment target for the patient with HCC.

Citing Articles

Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1.

Xie B, Wu P, Liu H, Yang X, Huang L J Transl Med. 2025; 23(1):165.

PMID: 39920781 PMC: 11806857. DOI: 10.1186/s12967-025-06128-8.


Inferring single-cell and spatial microRNA activity from transcriptomics data.

Herbst E, Mandel-Gutfreund Y, Yakhini Z, Biran H Commun Biol. 2025; 8(1):87.

PMID: 39827321 PMC: 11743151. DOI: 10.1038/s42003-025-07454-9.


Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p.

Chen Z, Du Y, Shi H, Dong S, He R, Zhou W Transl Cancer Res. 2024; 13(8):4113-4130.

PMID: 39262472 PMC: 11385540. DOI: 10.21037/tcr-24-51.


Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review.

Chen Z, Guan D, Zhu Q, Wang Z, Han F, Zhou W Curr Issues Mol Biol. 2023; 45(11):8864-8881.

PMID: 37998733 PMC: 10670187. DOI: 10.3390/cimb45110556.


LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.

Pei L, Yan D, He Q, Kong J, Yang M, Ruan H Cell Oncol (Dordr). 2023; 46(5):1509-1527.

PMID: 37355516 PMC: 10618329. DOI: 10.1007/s13402-023-00826-5.


References
1.
Wallace M, Preen D, Jeffrey G, Adams L . The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015; 9(6):765-79. DOI: 10.1586/17474124.2015.1028363. View

2.
Luan W, Ding Y, Ma S, Ruan H, Wang J, Lu F . Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis. Cell Death Dis. 2019; 10(11):855. PMC: 6848151. DOI: 10.1038/s41419-019-2090-3. View

3.
Zhao L, Hu K, Cao J, Wang P, Li J, Zeng K . lncRNA functions as a ceRNA to upregulate by sponging in HCC cellular senescence. Aging (Albany NY). 2019; 11(17):7098-7122. PMC: 6756895. DOI: 10.18632/aging.102240. View

4.
Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J . PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop. Oncotarget. 2015; 6(15):13006-18. PMC: 4536995. DOI: 10.18632/oncotarget.3514. View

5.
Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y . Long non-coding RNA: a new player in cancer. J Hematol Oncol. 2013; 6:37. PMC: 3693878. DOI: 10.1186/1756-8722-6-37. View